Company Filing History:
Years Active: 2006-2014
Title: Innovations of Gregory Nikiforovich
Introduction
Gregory Nikiforovich is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of medical treatments, particularly in addressing tissue inflammation and carcinogenesis. With a total of four patents to his name, his work has the potential to impact various health conditions.
Latest Patents
One of Gregory's latest patents involves guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis. This method discloses a treatment for inflamed, pre-cancerous, or cancerous tissue or polyps in a mammalian subject. The treatment consists of administering a composition that includes at least one peptide agonist of a guanylate cyclase receptor and/or other small molecules that enhance intracellular production of cGMP. The peptide agonist may be used alone or in combination with an inhibitor of cGMP-dependent phosphodiesterase. This innovative approach aims to restore a healthy balance between cell proliferation and apoptosis, thereby suppressing carcinogenesis. The method can be applied to treat various conditions, including gastrointestinal inflammatory disorders, general organ inflammation, asthma, and carcinogenesis affecting the lung, gastrointestinal tract, bladder, testis, prostate, and pancreas.
Career Highlights
Throughout his career, Gregory has worked with prominent companies in the pharmaceutical industry, including Synergy Pharmaceuticals, Inc. and Callisto Pharmaceuticals. His experience in these organizations has contributed to his expertise in developing innovative treatments.
Collaborations
Gregory has collaborated with notable professionals in his field, including Kunwar Shailubhai and Gary S Jacob. These partnerships have likely enhanced his research and development efforts.
Conclusion
Gregory Nikiforovich is a distinguished inventor whose work in medical treatments has the potential to significantly improve patient outcomes. His innovative approaches to addressing tissue inflammation and carcinogenesis reflect his commitment to advancing healthcare solutions.